Every clinical label is a critical and consequential communication between your study and your patients. Poor or inconsistent translations aren’t just a nuisance, they can result in regulatory risk, protracted timelines—and patient safety issues.
ATLASSM, our Alternative Translation and Label Approval System, simplifies the complexities of clinical label translations and regulatory approvals, with efficiency, speed, and confidence.
And combining ATLAS translation services with our in-house label design and manufacturing capabilities can yield further efficiencies, reducing cycle times across the entire label creation process—including translations—from start to
finish.